These transactions have the effect of increasing the effective conversion price of the notes, from AmeriCredit's perspective, to $35 (in the case of the 2011 notes) or $40 (in the case of the 2013 notes), which represents approximately a 43% premium (in the case of the 2011 notes) or approximately a 64% premium (in the case of the 2013 notes), in each case to the closing price
of AmeriCredit's common stock on September 12, 2006.
NASDAQ:BDSI), a specialty biopharmaceutical company, has closed a transaction with Clinical Development Capital, LLC ("CDC") pursuant to which $7 million in funds previously committed by CDC in July 2005 to fund the clinical development of BDSI's flagship BEMA(TM) Fentanyl product have been converted into shares of BDSI common stock at a 40 % premium to the May 16, 2006 closing price
for BDSI's shares.
5 million shares of Reliance common stock valued at about $387 million based on the Reliance 20-day average closing price
The lists of Friday closing prices
for the various exchanges no longer will be printed on Saturday because most readers get this information in the Sunday paper.
Furthermore, the NASDAQ Official Closing Price
imposes reasonability standards on the closing price
by ensuring that it is at, or within NASDAQ's best bid and ask quotations.
It is the closing price
divided by the company's earnings per share.
The Egyptian Stock Exchange (EGX) will implement a new closing price
mechanism on Thursday.
The notes will mature on December 1, 2024, and will not be redeemable by the Company prior to December 1, 2009, except after December 1, 2007, the Company can redeem the notes if the closing price
of the common stock exceeds 150% of the conversion price for 20 trading days in the 30-trading day period before a redemption notice.
The offer price is higher than the highest closing price
of Ingersoll-Rand India for the last five years and represents a compelling exit opportunity for Ingersoll-Rand India shareholders.
Second graph, second sentence should read: The Company then, with full Board of Directors approval, purchased the resulting 1 million shares of common stock at fair market value equal to the December 10, 2004 closing price
of the Company's common stock as reported by Nasdaq (sted: The Company then, with full Board of Directors approval, purchased the resulting 1 million shares of common stock at fair market value equal to the December 8, 2004 closing price
of the Company's common stock as reported by Nasdaq).
29 per share, which is a 20% premium over yesterday's closing price
The Fund's daily closing price
and net asset value per share as well as other related information can be found at www.